Healthcare DIVE December 16, 2025
The drug distributor has been steadily building up its specialty support assets as it looks to increase access to drugs.
Dive Brief:
- Cencora is acquiring a majority stake in OneOncology, a support platform for cancer care practices, for $5 billion as the drug distributor ramps up its specialty services offerings.
- Cencora already owned a stake in OneOncology, but has signed a definitive agreement to acquire most of the remaining shares from investment firm TPG and other holders for $3.6 billion, and to pay off $1.3 billion of OneOncology’s debt.
- OneOncology’s practices will retain a minority interest in the company, according to a release. Cencora expects deal to close by the second fiscal quarter next year.
Dive Insight:
Analysts...
Today's Sponsors
Today's Sponsor